Similar articles

• Endocrine treatment of metastatic cancer of the breast and prostate.

  LUFT R, OLIVERCRONA H, IKKOS D. LUFT R, et al. Acta Endocrinol Suppl (Copenh). 1957;24(Suppl 31):241-53. doi: 10.1530/acta.0.024s241. Acta Endocrinol Suppl (Copenh). 1957. PMID: 13443784 No abstract available.
• [Endocrine treatment of metastatic cancer of breast and prostate].

  LUFT R, OLIVECRONA H, IKKOS D. LUFT R, et al. Nord Med. 1957 Jan 24;57(4):127-30. Nord Med. 1957. PMID: 13419106 Norwegian. No abstract available.
• Endocrine therapy of metastatic breast cancer.

  LIPSETT MB, PEARSON OH. LIPSETT MB, et al. Postgrad Med. 1957 Jun;21(6):571-6. doi: 10.1080/00325481.1957.11691813. Postgrad Med. 1957. PMID: 13431580 No abstract available.
• [Hormonal treatment of advanced prostate cancer].

  Faris G, Stein A, Lurie A. Faris G, et al. Harefuah. 1993 Jan 1;124(1):35-40. Harefuah. 1993. PMID: 8436310 Review. Hebrew. No abstract available.
• The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers.

  Rau KM, Kang HY, Cha TL, Miller SA, Hung MC. Rau KM, et al. Endocr Relat Cancer. 2005 Sep;12(3):511-32. doi: 10.1677/erc.1.01026. Endocr Relat Cancer. 2005. PMID: 16172190 Review.